Accessibility Menu
LifeMD logo

LifeMD(NASDAQ) LFMDP

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+68%
5 YearN/A
1 Year+7%
1 Month+2%
$23.33
-0.92%
-0.22Today
LifeMD last closing stock price
MetricPriceDate
Last closeUSD 23.332026-07-27
LifeMD stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.08%USD 23.352026-07-20
1 month+1.86%USD 22.902026-06-26
3 month+1.02%USD 23.092026-04-28
Year to date+13.7%USD 20.522025-12-31
1 year+6.79%USD 21.852025-07-25
3 year+63.94%USD 14.232023-07-28
Since inception+68.47%USD 13.982021-10-05

LifeMD Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$219.42M

Net Income (TTM)

-$16.25M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$2.22

Beta (Volatility)

0.22 (Low)

Price

$23.33

Volume

340

Open

$23.33

Previous Close

$23.33

Daily Range

$23.33 - $23.33

52-Week Range

$18.50 - $24.34

Estimated Earnings Date

Aug 6, 2026

LFMDP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LifeMD

LifeMD, Inc. operates as a direct-to-patient telehealth enterprise, connecting individuals with healthcare professionals across the United States. The company offers a diverse range of medical services, including personalized concierge care and specialized treatments in areas such as men's sexual health and dermatology.

Products and Services
  • ShapiroMD provides comprehensive hair loss solutions through virtual consultations and prescription medications
  • RexMD offers virtual medical treatment for various men's health needs
  • LifeMD Primary Care delivers personalized virtual primary and urgent care services
Growth Outlook
  • Revenue increased to $50.16 million in Q1 2026, up from $46.87 million in Q4 2025
  • Gross profit margin improved to 84.85% in Q1 2026, indicating operational efficiency
  • Strong demand for telehealth services is expected to drive future growth
Financial Highlights
  • Net income for Q1 2026 was -$8.87 million, reflecting ongoing investment in growth
  • Cash and cash equivalents stood at $34.48 million as of March 31, 2026
  • Operating cash flow was positive at $444,624 in Q1 2026, indicating operational stability
LifeMD, Inc. is positioned in the rapidly growing telehealth sector, which has gained significant traction due to increased demand for remote healthcare services. The company's diverse portfolio of telehealth brands allows it to cater to various medical needs, enhancing its market presence. Recent financial performance shows a positive trend in revenue growth and gross profit margins, suggesting effective management and operational efficiency. The company continues to invest in its services, which may lead to further expansion and profitability in the future.
AI Generated • Jul 16, 2026

Industry

Health Care Technology

Headquarters

New York City, NY 10001, US

LFMDP Financials

Key Financial Metrics (TTM)

Gross Margin

85.89%

Operating Margin

-5.88%

Net Income Margin

-7.41%

Return on Equity

-172.30%

Return on Capital

-26.02%

Return on Assets

-23.17%

Earnings Yield

N/A

Dividend Yield

9.42%

Payout Ratio

-19.11%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

340

Avg. Volume

2.12K

Financials (TTM)

Gross Profit

$188.46M

Operating Income

-$12.90M

EBITDA

-$4.22M

Operating Cash Flow

$5.66M

Capital Expenditure

$9.17M

Free Cash Flow

$14.83M

Cash & ST Invst.

$34.48M

Total Debt

$6.17M

LifeMD Performance Analysis

LifeMD sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-5.3%
Q32025-09-30-3.3%
Q42025-12-31-22.1%
Q12026-03-317.0%
LifeMD sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-582.7%
Q32025-09-30-54.7%
Q42025-12-3151.1%
Q12026-03-31-311.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$50.16M

-23.6%

Gross Profit

$42.56M

-25.4%

Gross Margin

84.85%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

304

N/A

Net Income

-$8.87M

-740.7%

EBITDA

-$6.88M

-232.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$34.48M

+0.2%

Total Debt

$6.17M

-75.4%

Accounts Receivable

$9.86M

-3.3%

Inventory

$3.18M

+7.1%

Long Term Debt

$5.50M

-57.7%

Short Term Debt

$670.83K

-94.5%

Return on Assets

-23.17%

N/A

Return on Invested Capital

-62.82%

N/A

Free Cash Flow

$339.45K

+68.8%

Operating Cash Flow

$444.62K

-85.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DNTHDianthus Therapeutics, Inc.
$104.49+0.60%
ELVNEnliven Therapeutics, Inc.
$52.74-0.41%
PLSEPulse Biosciences, Inc.
$32.79+8.47%
OPKOPKO Health, Inc.
$1.24+1.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$63.40-0.01%
SPCXSpace Exploration Technologies
$113.50-0.01%

Questions About LFMDP

What is the current price of LifeMD?

LifeMD is trading at $23.33 per share.

What is the 52-week range for LifeMD?

Over the past 52 weeks, LifeMD has traded between $18.50 and $24.34.

How much debt does LifeMD have?

LifeMD total debt is unavailable.

How much cash does LifeMD have on hand?

LifeMD does not have cash on hand data available.

What is LifeMD’s dividend yield?

LifeMD currently has a dividend yield of 9.42%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.